ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Barleria

Also known as: Barleria cristata, Barleria prionitis, Barleria

Overview

Barleria is a genus of plants native to tropical regions, with two species, Barleria cristata and Barleria prionitis, being commonly studied for their medicinal properties. These plants are traditionally used in herbal medicine for various applications, primarily for their anti-inflammatory and antimicrobial potential. They contain a range of bioactive compounds, including flavonoids and alkaloids, which are believed to contribute to their therapeutic effects. While traditional uses are widespread, the scientific research on Barleria species is still in its early stages, predominantly consisting of in vitro and animal studies. There is a notable lack of comprehensive human trials, systematic reviews, or meta-analyses, indicating that the evidence base for their efficacy and safety as supplements is currently limited.

Benefits

Research on Barleria species suggests potential anti-inflammatory effects, primarily observed in animal models. For instance, studies have shown that Barleria cristata can reduce histamine-induced rat paw edema, indicating its anti-inflammatory properties. However, these findings have not yet been replicated or confirmed in human trials, meaning the strength of evidence for human benefit is currently low. There is also preliminary suggestion of potential anti-diabetic effects, but this area requires significant further investigation. No specific population-specific benefits have been identified, and the clinical significance or effect sizes of these potential benefits cannot be quantified due to the absence of human data. The time course for any potential benefits is also unknown.

How it works

The anti-inflammatory effects of Barleria species are thought to involve the modulation of inflammatory mediators within the body. While the exact molecular targets are not well-defined, the presence of bioactive compounds like flavonoids and alkaloids suggests an interaction with the immune system's inflammatory pathways. There is also speculative interaction with the metabolic system, particularly concerning the potential anti-diabetic effects. However, detailed studies on the absorption, bioavailability, and specific biological pathways through which Barleria exerts its effects are currently lacking.

Side effects

The overall safety profile of Barleria species is not well-established due to a significant lack of formal safety studies and human trials. While traditional use might suggest a degree of safety, common, uncommon, or rare side effects have not been identified or documented in a scientific context. Similarly, potential drug interactions are speculative and require thorough investigation, as no formal interactions have been identified. There are no formally identified contraindications. Furthermore, specific guidance for vulnerable populations such as pregnant women, children, or individuals with pre-existing conditions is unavailable, as no special population considerations have been studied. Users should exercise caution and consult healthcare professionals before using Barleria supplements.

Dosage

Currently, there are no established dosing guidelines for Barleria species as a supplement. The minimum effective dose, optimal dosage ranges, and maximum safe dose have not been determined due to the lack of human clinical trials. Information regarding timing considerations for administration, form-specific recommendations (e.g., extract vs. whole plant), absorption factors, or required cofactors is also unknown. Without sufficient scientific data from human studies, it is not possible to provide evidence-based recommendations for the usage of Barleria supplements.

FAQs

Is Barleria safe to use as a supplement?

The safety of Barleria as a supplement is not well-established due to a lack of human trials and formal safety studies. While traditionally used, scientific data on side effects, drug interactions, or contraindications are limited. It is advisable to consult a healthcare professional before use.

What are the proven benefits of Barleria?

Current research on Barleria primarily shows potential anti-inflammatory effects in animal models. However, these findings have not been confirmed in human studies, meaning there are no proven benefits for humans at this time. Further research is needed to validate its efficacy.

How should I take Barleria, and what is the recommended dosage?

There are no established dosing guidelines, optimal dosages, or specific timing recommendations for Barleria. The lack of human clinical data means that effective and safe usage instructions cannot be provided. Always seek advice from a healthcare provider.

Can Barleria interact with other medications?

Potential drug interactions with Barleria are currently unknown and speculative due to the absence of formal studies. It is crucial to inform your healthcare provider about any supplements you are taking, including Barleria, to avoid potential adverse interactions.

Research Sources

  • https://www.ijpsjournal.com/article/A+Comprehensive+Review+On+Barleria+Cristata+Linn+Acanthaceae – This review summarizes the anti-inflammatory efficacy of Barleria cristata in animal models. It highlights the need for further pharmacotherapeutic studies to establish its safety and efficacy in humans, indicating that current evidence is insufficient for human application.
  • https://jurnal.globalhealthsciencegroup.com/index.php/IJGHR/article/view/4336 – This study focused on the standardization and antiglycation activity of Barleria prionitis leaf extract. It suggests potential for medicinal applications but lacks direct human trial data, emphasizing that its therapeutic use requires more rigorous investigation.
  • https://pubmed.ncbi.nlm.nih.gov/35940344/ – This systematic review on flavonoids, not specific to Barleria, showed their potential in preventing acute respiratory tract infections. While it highlights the broader potential of herbal supplements, it does not directly apply to Barleria without specific studies on its efficacy in this area.